Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Major Route Additional Chromosomal Aberrations (ACA) Precede Increase of Blasts in CML: An Analysis of the German CML-Studies III and IIIA

Christian T. Dietz, PhD, Alice Charlotte Fabarius, PhD, Michael Lauseker, PhD, Susanne Saussele, Lida Kalmanti, Sébastien Rinaldetti, Claudia Haferlach, MD, Brigitte Schlegelberger, MD PhD, Martine Jotterand, Alois Gratwohl, Axel R. Zander, Professor, Nicolaus Kröger, Dietrich W. Beelen, MD, Jürgen Novotny, Christoph Nerl, Christof Scheid, MD PhD, Karsten Spiekermann, Jiri Mayer, MD, Herbert G. Sayer, Christiane Falge, Donald Bunjes, MD, Hartmut Döhner, Prof. Dr., Arnold Ganser, Peter Brossart, MD, Rainer Schwerdtfeger, Herrad Baumann, Rolf Kuse, Hans Walter Lindemann, MD, Matthias Bormann, Bernd Hertenstein, MD, Gabriela M. Baerlocher, Carlo Aul, MD, Peter Staib, Matthias Edinger, MD, Michael Schatz, Axel A Fauser, Renate Arnold, MD, Dieter K. Hossfeld, MD, Hans-Jochem Kolb, Susanne Schnittger, PhD, Martin C. Müller, MD, Andreas Reiter, MD, Andreas Hochhaus, MD, Markus Pfirrmann, Joerg Hasford, Michele Baccarani, Ruediger Hehlmann, MD

Blood (2015) 126 (23): 1581.

https://doi.org/10.1182/blood.V126.23.1581.1581

Published: 2015

Journal Articles

Shift to a New Donor Does Not Improve the Outcome After Second Allogeneic Stem Cell Transplantation (alloSCT) in Acute Leukemia Relapse After a First Allosct – a Risk Factor Analysis by the German Stem Cell Registry (DRST).

Blood (2009) 114 (22): 3328.

https://doi.org/10.1182/blood.V114.22.3328.3328

Published: 2009

Journal Articles

Monitoring of Donor Chimerism in CD34+ Peripheral Blood Progenitors Allows to Detect Minimal Residual Disease after Allogeneic Stem Cell Transplantation -Results of a Randomized Trial

Martin Bornhaeuser, Uta Oelschlaegel, Gesine Bug, Uwe Platzbecker, Karin Lutterbeck, Michael G Kiehl, Johannes Schetelig, Alexander Kiani, Thomas Illmer, Markus Schaich, MD, Catrin Theuser, Brigitte Mohr, Cornelia Brendel, Axel A Fauser, Stefan Klein, Hans Martin, Gerhard Ehninger, MD, Christian Thiede

Blood (2008) 112 (11): 340.

https://doi.org/10.1182/blood.V112.11.340.340

Published: 2008

Journal Articles

Conditioning with 8-Gy total body irradiation and fludarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia

Matthias Stelljes, Martin Bornhauser, Matthias Kroger, Joerg Beyer, Maria C. Sauerland, Achim Heinecke, Bjorna Berning, Christian Scheffold, Gerda Silling, Thomas Buchner, Andreas Neubauer, Axel A. Fauser, Gerhard Ehninger, Wolfgang E. Berdel, Joachim Kienast, for the Cooperative German Transplant Study Group

Blood (2005) 106 (9): 3314–3321.

https://doi.org/10.1182/blood-2005-04-1377

Published: 2005

Journal Articles

Early In Vivo Depletion of Suicide Gene-Modified T-Lymphocytes Transplanted in Conjunction with CD34 + Enriched Blood Stem Cells May Be Associated with an Increased Risk of Secondary Graft Failure.

Boris Fehse, PhD, Francis A. Ayuk, MD, Nicolaus Kröger, MD, Lubin Fang, MD, Klaus Kühlcke, PhD, Marion Heinzelmann, Tatjana Zabelina, MD, Axel A. Fauser, MD, PhD, Axel R. Zander, MD

Blood (2004) 104 (11): 1742.

https://doi.org/10.1182/blood.V104.11.1742.1742

Published: 2004

Journal Articles

Evidence for increased risk of secondary graft failure after in vivo depletion of suicide gene-modified T lymphocytes transplanted in conjunction with CD34 + -enriched blood stem cells

Boris Fehse, Francis A. Ayuk, Nicolaus Kröger, Lubin Fang, Klaus Kühlcke, Marion Heinzelmann, Tatjana Zabelina, Axel A. Fauser, Axel R. Zander

Blood (2004) 104 (10): 3408–3409.

https://doi.org/10.1182/blood-2004-07-2813

Published: 2004

Journal Articles

Eosinophilia indicates the evolution to acute graft-versus-host disease

Nadezda Basara, Michael G. Kiehl, Axel A. Fauser

Blood (2002) 100 (8): 3055.

https://doi.org/10.1182/blood-2002-04-1118

Published: 2002

Journal Articles

No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors

Mats Remberger, Oolle Ringdén, Igor-Wolfgang Blau, Hellmut Ottinger, Bernhard Kremens, Micheil G. Kiehl, Johan Aschan, Dietrich W. Beelen, Nadezda Basara, Gunilla Kumlien, Axel A. Fauser, Volker Runde

Blood (2001) 98 (6): 1739–1745.

https://doi.org/10.1182/blood.V98.6.1739

Published: 2001

Journal Articles

Interferon- Before Allogeneic Bone Marrow Transplantation in Chronic Myelogenous Leukemia Does Not Affect Outcome Adversely, Provided It Is Discontinued at Least 90 Days Before the Procedure

Blood (1999) 94 (11): 3668–3677.

https://doi.org/10.1182/blood.V94.11.3668

Published: 1999

Journal Articles

High Efficiency Gene Transfer to Human Hematopoietic SCID-Repopulating Cells Under Serum-Free Conditions

Andrea J. Schilz, Gaby Brouns, Heike Knöβ, Oliver G. Ottmann, Dieter Hoelzer, Axel A. Fauser, Adrian J. Thrasher, Manuel Grez

Blood (1998) 92 (9): 3163–3171.

https://doi.org/10.1182/blood.V92.9.3163

Published: 1998

NARROW

Major Route Additional Chromosomal Aberrations (ACA) Precede Increase of Blasts in CML: An Analysis of the German CML-Studies III and IIIA

Shift to a New Donor Does Not Improve the Outcome After Second Allogeneic Stem Cell Transplantation (alloSCT) in Acute Leukemia Relapse After a First Allosct – a Risk Factor Analysis by the German Stem Cell Registry (DRST).

Monitoring of Donor Chimerism in CD34+ Peripheral Blood Progenitors Allows to Detect Minimal Residual Disease after Allogeneic Stem Cell Transplantation -Results of a Randomized Trial

Conditioning with 8-Gy total body irradiation and fludarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia

Early In Vivo Depletion of Suicide Gene-Modified T-Lymphocytes Transplanted in Conjunction with CD34 + Enriched Blood Stem Cells May Be Associated with an Increased Risk of Secondary Graft Failure.

Evidence for increased risk of secondary graft failure after in vivo depletion of suicide gene-modified T lymphocytes transplanted in conjunction with CD34 + -enriched blood stem cells

Eosinophilia indicates the evolution to acute graft-versus-host disease

No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors

Interferon- Before Allogeneic Bone Marrow Transplantation in Chronic Myelogenous Leukemia Does Not Affect Outcome Adversely, Provided It Is Discontinued at Least 90 Days Before the Procedure

High Efficiency Gene Transfer to Human Hematopoietic SCID-Repopulating Cells Under Serum-Free Conditions

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only